Skip to main content
Supplement ScienceSupplementScience

D-Aspartic Acid Research & Evidence

·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence Level

Preliminary

D-Aspartic Acid (DAA) has been studied for its potential effects on hormonal profiles and reproductive health. A 2009 study by Topo et al. demonstrated that DAA supplementation led to a significant increase in testosterone levels, though subsequent research has yielded inconsistent results. For instance, Willoughby and Leutholtz (2013) reported no notable changes in testosterone levels among resistance-trained men after DAA supplementation, while Melville et al. (2015) also observed no significant effects on hormonal markers in a group of young, active males.

Recent studies have explored the potential benefits of DAA for specific populations. GamalEl Din et al. (2025) conducted a randomized double-blind placebo-controlled trial with 75 participants and found that DAA, when combined with ubiquinol and zinc, significantly improved sperm motility and testosterone levels in men with idiopathic male infertility. This suggests that DAA may be more effective for individuals with suboptimal hormonal status due to age or lifestyle factors.

In contrast, other studies have reported no significant effects of DAA supplementation on hormonal responses. For example, Płoszczyca et al. (2023) examined the impact of 6g/day DAA on male boxers exposed to hypoxic conditions and found no changes in testosterone or cortisol levels. Similarly, Crewther et al. (2019) observed no significant effects on serum biomarkers associated with the hypothalamic-pituitary-gonadal axis in a group of male climbers.

Overall, while DAA may offer benefits for individuals with subfertile conditions or low testosterone levels, its efficacy appears limited in young, active men with already-optimal hormonal profiles.

Evidence by Condition

ConditionStudied DoseEvidence
Testosterone support (untrained men)2-3 g daily for 12-28 daysPreliminary
Male fertility2.66 g daily for 90 daysPreliminary

References

  1. RCTWilloughby DS, Leutholtz B. (2013). D-aspartic acid supplementation combined with 28 days of heavy resistance training has no effect on body composition, muscle strength, and serum hormones. Nutrition Research. DOI PubMed
  2. RCTMelville GW, Siegler JC, Marshall PW. (2015). Three and six grams supplementation of d-aspartic acid in resistance trained men. Journal of the International Society of Sports Nutrition. DOI PubMed
  3. RCTGamalEl Din SF, A M E, Elkhiat Y, Hussein T, et al. (2025). Evaluation of in vivo supplementation of 2660 mg D-aspartic acid and 200 mg ubiquinol and 10 mg zinc on different semen parameters in idiopathic male infertility: a randomized double blind placebo controlled study.. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica. DOI PubMed
  4. RCTPłoszczyca K, Czuba M, Zakrzeska A, Gajda R (2023). The Effects of Six-Gram D-Aspartic Acid Supplementation on the Testosterone, Cortisol, and Hematological Responses of Male Boxers Subjected to 11 Days of Nocturnal Exposure to Normobaric Hypoxia.. Nutrients. DOI PubMed
  5. Crewther B, Witek K, Draga P, Zmijewski P, et al. (2019). Short-Term d-Aspartic Acid Supplementation Does Not Affect Serum Biomarkers Associated With the Hypothalamic-Pituitary-Gonadal Axis in Male Climbers.. International journal of sport nutrition and exercise metabolism. DOI PubMed
  6. Melville GW, Siegler JC, Marshall PWM (2017). The effects of d-aspartic acid supplementation in resistance-trained men over a three month training period: A randomised controlled trial.. PloS one. DOI PubMed
  7. Abbasi B, Kimiagar M, Sadeghniiat K, Shirazi MM, et al. (2012). The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial.. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences. PubMed
Show 2 more references
  1. Tricco AC, Vandervaart S, Soobiah C, Lillie E, et al. (2012). Efficacy of cognitive enhancers for Alzheimer's disease: protocol for a systematic review and network meta-analysis.. Systematic reviews. DOI PubMed
  2. RCTTopo E, Soricelli A, D'Aniello A, et al. (2009). The role and molecular mechanism of D-aspartic acid in the release and synthesis of LH and testosterone in humans and rats. Reproductive Biology and Endocrinology. DOI PubMed